Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion

Abortion Facility Closures Behind Delaware’s Abortion Decline

Editor’s Note: Delaware’s clinic closures appear to be internally driven and due, in large part, to gross legal and medical violations surrounding multiple abortion practitioners in the state. The 2019 edition of Americans United for Life’s survey of state laws on abortion states: “Delaware maintains only minimal protections for a woman considering an abortion. ‘Loopholes’ in its parental notice law eviscerate the protection such a law normally provides, and Delaware does not require that abortion facilities meet minimal health and safety standards.”

 

 

Last month, The New York Times published an article about Delaware’s efforts to make contraception more available to its residents. Starting in 2014, Delaware partnered with the company Upstream to offer a range of free contraceptive services to women who visit health care providers.  According to the article, long-acting reversible contraceptives, like IUDs and implants, have been popular among both patients and doctors. Indeed, data presented in the article indicates that the percentage of Delaware family planning patients who are using a long-acting reversible contraceptive has increased since 2014.  The Times article is supportive of the program and even states that conservative critics should appreciate the fact that Delaware’s abortion rate dropped a year after Upstream arrived, and that the health department expects it to fall again.

 

However, a closer look at Delaware abortion trends raises questions about the role of this program in reducing the incidence of abortion in Delaware…

 

Originally published at CNSNews.com. Click to continue reading.

 

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

A graphic showing an outline of Kentucky with the text KENTUCKY ABORTION STATISTICS centered over it, detailing 2022 abortion data.

Abortion Reporting: Kentucky (2025)

An outline of the state of Alabama with the text ALABAMA ABORTION STATISTICS centered over it, reflecting current abortion reporting.

Abortion Reporting: Alabama (2025)

Text reading Virginia Abortion Statistics, providing 2022 abortion data, centered over a light gray silhouette of the state of Virginia inside a white circle on a blue background.

Abortion Reporting: Virginia (2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image